Correlation Between Orchestra BioMed and Keros Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Keros Therapeutics, you can compare the effects of market volatilities on Orchestra BioMed and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Keros Therapeutics.

Diversification Opportunities for Orchestra BioMed and Keros Therapeutics

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Orchestra and Keros is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Keros Therapeutics go up and down completely randomly.

Pair Corralation between Orchestra BioMed and Keros Therapeutics

Given the investment horizon of 90 days Orchestra BioMed Holdings is expected to generate 1.75 times more return on investment than Keros Therapeutics. However, Orchestra BioMed is 1.75 times more volatile than Keros Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  546.00  in Orchestra BioMed Holdings on September 3, 2024 and sell it today you would earn a total of  17.00  from holding Orchestra BioMed Holdings or generate 3.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Orchestra BioMed Holdings  vs.  Keros Therapeutics

 Performance 
       Timeline  
Orchestra BioMed Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Orchestra BioMed is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Keros Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Orchestra BioMed and Keros Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orchestra BioMed and Keros Therapeutics

The main advantage of trading using opposite Orchestra BioMed and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.
The idea behind Orchestra BioMed Holdings and Keros Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal